Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

triprolyl angiotensin II

Known as: angiotensin II, N-(1-(1-prolyl-prolyl)-prolyl)-isoleucine(5)-, angiotensin II, Pro-Pro-Pro-, angiotensin II, prolyl, prolyl, proline- 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Angiotensin II
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Imbalance between Angiotensin II - Angiotensin (1-7) system is associated with vascular endothelial dysfunction and inflammation in type 2 diabetes with newly diagnosed hypertension.
AIM Diabetes is associated with Renin-angiotensin-aldosterone-system (RAAS) activation. Protective role of Angiotensin (1-7) has… 
2017
2017
Critical role of vascular peroxidase 1 in regulating endothelial nitric oxide synthase
Vascular peroxidase 1 (VPO1) is a member of the peroxidase family which aggravates oxidative stress by producing hypochlorous… 
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2017
2017
Calcitriol Ameliorates AngiotensinII-Induced Renal Injury Partly via Upregulating A20
Inflammation and reactive oxygen species (ROS) play crucial roles in the progression of chronic kidney diseases. Vitamin D has… 
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
2010
2010
Effect of theTEOS /Al(i-pro)3 mol ratio in the composition on the crystal morphology of zeolites
The interest is focused on the control of crystal morphology of single phase zeolite nanocrystals from cube, LTA to octahedron… 
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Highly Cited
2005
Highly Cited
2005
Common angiotensin receptor blockers may directly modulate the immune system via VDR, PPAR and CCR2b
BackgroundThere have been indications that common Angiotensin Receptor Blockers (ARBs) may be exerting anti-inflammatory actions… 
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 15
Review
2001
Review
2001
The Treatment and Prevention for Cardiac Hypertrophy by AngiotensinII Recerptor Antagonist
Left ventricle hypertrophy(LVH) is one of the dangerous factors that are linked with the increasing incidences and mortality of… 
1987
1987
Selective Pharmacological Effects of Triprolyl and Pentasarcosyl Angiotensin II
Among the various biological effects of angiotensin II (All), both pressor activity and aldosterone stimulation appear to be… 
1980
1980
Acute effects of saralasin on plasma aldosterone in different pathophysiological conditions.
The effect of the angiotensin II analog, saralasin (l-sar-8-ala-angiotensinII), on plasma aldosterone (PA) and plasma cortisol… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE